日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial

在蒙古，非mRNA免疫后，分段注射BNT162b2加强针可诱导持久的免疫反应：一项随机对照试验

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1789248
Batmunkh, Tsetsegsaikhan; Neal, Eleanor Fg; Amraa, Otgonjargal; Mazarakis, Nadia; Altangerel, Bolor; Avaa, Naranbaatar; Batbayar, Lkhagvagaram; Batsukh, Khishigjargal; Bright, Kathryn; Burentogtokh, Tsogjargal; Do, Lien Anh Ha; Dorj, Gantuya; Hart, John D; Jamiyandorj, Otgonbold; Javkhlantugs, Khulan; Jigjidsuren, Sarantsetseg; Justice, Frances; Li, Shuo; Mashbaatar, Khaliunaa; Moore, Kerryn A; Namjil, Narantuya; Nguyen, Cattram D; Ochirbat, Batbayar; Surenjav, Unursaikhan; Thomson, Helen; Tsolmon, Bilegtsaikhan; Licciardi, Paul V; von Mollendorf, Claire; Mulholland, Kim
免疫/内分泌
发表日期：2026
文献求助 收藏

Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial

在蒙古，一项随机、对照、非劣效性试验评估了接种两剂 ChAdOx1 nCoV-19、BBIBP-CorV 或 Gam-COVID-Vac 疫苗后，接种半剂量与全剂量 BNT162b2（辉瑞-BioNTech）加强针的免疫原性、安全性和反应原性。

期刊:The Lancet Regional Health Western Pacific
影响因子:8.1
doi:10.1016/j.lanwpc.2023.100953
Batmunkh, Tsetsegsaikhan; Moore, Kerryn A; Thomson, Helen; Altangerel, Bolor; Amraa, Otgonjargal; Avaa, Naranbaatar; Batbayar, Lkhagvagaram; Batsukh, Khishigjargal; Bright, Kathryn; Burentogtokh, Tsogjargal; Ha Do, Lien Anh; Dorj, Gantuya; Hart, John D; Javkhlantugs, Khulan; Jigjidsuren, Sarantsetseg; Justice, Frances; Li, Shuo; Licciardi, Paul V; Mashbaatar, Khaliunaa; Mazarakis, Nadia; Neal, Eleanor F G; Nguyen, Cattram Duong; Ochirbat, Batbayar; Tsolmon, Bilegtsaikhan; Tuya, Alimaa; Surenjav, Unursaikhan; von Mollendorf, Claire; Mulholland, Kim
免疫/内分泌
发表日期：2024
文献求助 收藏